Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 46 referenced papers

Top Authors

Rodrigo Hasbun
The University of Texas Health Science Center
Diederik van de Beek
Amsterdam Neuroscience
Matthijs C. Brouwer
Amsterdam Neuroscience
Ray Borrow
Manchester Royal Infirmary
Jessica R. MacNeil
National Center for Immunization and Respiratory Diseases
Marjolein J. Lucas
Academic Medical Center
Muhamed‐Kheir Taha
Institut Pasteur
Helen Marshall
Women's and Children's Health Network
Shamez Ladhani
Animal and Plant Health Agency
Simon Nadel
St Mary's Hospital

Top Institutions

Ranked by publications Top 10 institutions
10

National Center for Immunization and Respiratory Diseases

Atlanta, United States

25 papers

References

References (46)
  1. 1

    Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

    Stoof SP, Rodenburg GD, Knol MJ, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; (61(8)):1281-92 doi:10.1093/cid/civ506.

    PMID: 26123933
  2. 2

    Meningococcemia in Adults: A Review of the Literature.

    Takada S, Fujiwara S, Inoue T, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(6)):567-72 doi:10.2169/internalmedicine.55.3272.

    PMID: 26984070
  3. 3

    Neurological sequelae of bacterial meningitis.

    Lucas MJ, Brouwer MC, van de Beek D

    The Journal of infection 2016; (73(1)):18-27.

    PMID: 27105658
  4. 4

    Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association.

    Dinkar A, Singh J, Atam V, et al.

    Journal of clinical and diagnostic research : JCDR 2016; (10(5)):OD03-4 doi:10.7860/JCDR/2016/17719.7719.

    PMID: 27437275
  5. 5

    Treatment of Meningococcal Disease.

    Nadel S

    The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2016; (59(2 Suppl)):S21-8.

    PMID: 27449146
  6. 6

    Bacterial Meningitis in Patients using Immunosuppressive Medication: a Population-based Prospective Nationwide Study.

    van Veen KEB, Brouwer MC, van der Ende A, van de Beek D

    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2017; (12(2)):213-218 doi:10.1007/s11481-016-9705-6.

    PMID: 27613024
  7. 7

    Atypical clinical presentation of meningococcal meningitis: a case report.

    Izzo I, Pileri P, Merello M, et al.

    Le infezioni in medicina 2016; (24(3)):234-6.

    PMID: 27668905
  8. 8

    Delayed recognition of fatal invasive meningococcal disease in adults.

    Nagel FW, Ezeoke I, Antwi M, et al.

    JMM case reports 2016; (3(3)):e005027 doi:10.1099/jmmcr.0.005027.

    PMID: 28348753
  9. 9

    Comparison of the inflammatory response of brain microvascular and peripheral endothelial cells following infection with Neisseria meningitidis.

    Dick J, Hebling S, Becam J, et al.

    Pathogens and disease 2017; (75(5)) doi:10.1093/femspd/ftx038.

    PMID: 28379411
  10. 10

    [Acute meningococcal disease in children and adolescents].

    Nygaard U, Vissing NH, Steensen M, et al.

    Ugeskrift for laeger 2017; (179(36)).

    PMID: 28874255
  11. 11

    Mutilating Purpura Fulminans in an Adult with Meningococcal Sepsis.

    Arnáiz-García ME, Arnáiz-García AM, Gutierrez-Diez F, et al.

    Puerto Rico health sciences journal 2017; (36(3)):179-182.

    PMID: 28915308
  12. 12

    Anti-inflammatory Drug Dexamethasone Treatment During the Remobilization Period Improves Range of Motion in a Rat Knee Model of Joint Contracture.

    Kaneguchi A, Ozawa J, Yamaoka K

    Inflammation 2018; (41(4)):1409-1423 doi:10.1007/s10753-018-0788-5.

    PMID: 29911276
  13. 13

    Long-term health and socioeconomic consequences of childhood and adolescent onset of meningococcal meningitis.

    Pickering L, Jennum P, Ibsen R, Kjellberg J

    European journal of pediatrics 2018; (177(9)):1309-1315 doi:10.1007/s00431-018-3192-0.

    PMID: 29923041
  14. 14

    Neisseria meningitidis Isolated in Vitreous Humor in a 5-Month-Old Infant Death From Meningococcal Sepsis.

    Garland J, Philcox W, Kesha K, et al.

    The American journal of forensic medicine and pathology 2019; (40(2)):175-177 doi:10.1097/PAF.0000000000000448.

    PMID: 30475234
  15. 15

    [Clinical aspects and treatment of invasive meningococcal infections]

    Parize P

    La Revue du praticien 2016; (66(3)):270-274.

    PMID: 30512636
  16. 16

    [Meningococcal sepsis without cerebrospinal fluid abnormalities under treatment with eculizumab].

    Jentzsch M, Schwind S, Vucinic V, et al.

    Medizinische Klinik, Intensivmedizin und Notfallmedizin 2020; (115(4)):340-342 doi:10.1007/s00063-019-0552-0.

    PMID: 30848313
  17. 17

    Neisseria meningitidis and cytomegalovirus simultaneous detection in the filmarray meningitis/encephalitis panel and its clinical relevance.

    Sorek N, Ashkenazi S, Livni G, Ben-Zvi H

    IDCases 2019; (17()):e00516 doi:10.1016/j.idcr.2019.e00516.

    PMID: 31193598
  18. 18

    Autopsy Biosafety: Recommendations for Prevention of Meningococcal Disease.

    Brooks EG, Utley-Bobak SR

    Academic forensic pathology 2018; (8(2)):328-339 doi:10.1177/1925362118782074.

    PMID: 31240046
  19. 19

    Serogroup diversity and antibiotic susceptibility of Neisseria meningitidis: Meningococcus infection monitoring in Belarus.

    Kharkhal HN, Titov LP

    Acta microbiologica et immunologica Hungarica 2019; (66(4)):443-457 doi:10.1556/030.66.2019.018.

    PMID: 31355666
  20. 20

    Lifetime costs of invasive meningococcal disease: A Markov model approach.

    Wang B, Haji Ali Afzali H, Giles L, Marshall H

    Vaccine 2019; (37(46)):6885-6893 doi:10.1016/j.vaccine.2019.09.060.

    PMID: 31594708
  21. 21

    Neisseria meningitidis Induced Fatal Waterhouse-Friderichsen Syndrome in a Patient Presenting With Disseminated Intravascular Coagulation and Multiple Organ Failure.

    Wu MY, Chen CS, Tsay CY, et al.

    Brain sciences 2020; (10(3)) doi:10.3390/brainsci10030171.

    PMID: 32192003
  22. 22

    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.

    Ladhani SN, Lucidarme J, Parikh SR, et al.

    Lancet (London, England) 2020; (395(10240)):1865-1877 doi:10.1016/S0140-6736(20)30913-2.

    PMID: 32534649
  23. 23

    Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital.

    Blanco BP, Branas PCAA, Yoshioka CRM, Ferronato AE

    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2020; (24(4)):337-342 doi:10.1016/j.bjid.2020.06.001.

    PMID: 32598866
  24. 24

    A Comprehensive Review of Meningococcal Disease Burden in India.

    Dutta AK, Swaminathan S, Abitbol V, et al.

    Infectious diseases and therapy 2020; (9(3)):537-559 doi:10.1007/s40121-020-00323-4.

    PMID: 32705485
  25. 25

    Meningococcus, this famous unknown.

    Dos Santos Souza I, Ziveri J, Bouzinba-Segard H, et al.

    Comptes rendus biologies 2021; (344(2)):127-143 doi:10.5802/crbiol.56.

    PMID: 34213851
  26. 26

    Genome-wide association studies reveal the role of polymorphisms affecting factor H binding protein expression in host invasion by Neisseria meningitidis.

    Earle SG, Lobanovska M, Lavender H, et al.

    PLoS pathogens 2021; (17(10)):e1009992 doi:10.1371/journal.ppat.1009992.

    PMID: 34662348
  27. 27

    Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.

    Saito R, Nakajima J, Prah I, et al.

    Microbiology spectrum 2022; (10(3)):e0062722 doi:10.1128/spectrum.00627-22.

    PMID: 35467371
  28. 28

    Carriage of Neisseria meningitidis Among Umrah Pilgrims: Circulating Serogroups and Antibiotic Resistance.

    Yezli S, Yassin Y, Mushi A, et al.

    Infection and drug resistance 2022; (15()):4685-4696 doi:10.2147/IDR.S375096.

    PMID: 36039322
  29. 29

    Progress and Challenges in Bacterial Meningitis: A Review.

    Hasbun R

    JAMA 2022; (328(21)):2147-2154 doi:10.1001/jama.2022.20521.

    PMID: 36472590
  30. 30

    Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis.

    Packnett ER, Zimmerman NM, Novy P, et al.

    Human vaccines & immunotherapeutics 2023; (19(1)):2165382 doi:10.1080/21645515.2023.2165382.

    PMID: 36715008
  31. 31

    Meningococcemia in an 11 Months Old Infant.

    Shrestha R, Karki S, Khadka M, et al.

    Case reports in infectious diseases 2023; (2023()):8951318 doi:10.1155/2023/8951318.

    PMID: 36936066
  32. 32

    Cerebrovascular complications in patients with community-acquired bacterial meningitis: occurrence and associated factors in the COMBAT multicenter prospective cohort.

    Benadji A, Debroucker T, Martin-Blondel G, et al.

    BMC infectious diseases 2023; (23(1)):376 doi:10.1186/s12879-023-08320-x.

    PMID: 37277727
  33. 33

    Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review.

    Kassianos G, Barasheed O, Abbing-Karahagopian V, et al.

    Infectious diseases and therapy 2023; (12(9)):2193-2219 doi:10.1007/s40121-023-00836-8.

    PMID: 37428339
  34. 34

    Not Only Meningitis but Also Epiglottitis: An Emerging Clinical Presentation of Invasive Meningococcal Disease.

    Deghmane AE, Taha S, Taha MK

    Open forum infectious diseases 2024; (11(1)):ofad615 doi:10.1093/ofid/ofad615.

    PMID: 38192380
  35. 35

    An isothermal CRISPR- based lateral flow assay for detection of Neisseria meningitidis.

    Huyen DT, Reboud J, Quyen DT, et al.

    Annals of clinical microbiology and antimicrobials 2024; (23(1)):28 doi:10.1186/s12941-024-00688-1.

    PMID: 38555443
  36. 36

    Life After Invasive Meningococcal Disease: Insights from Survivors and Their Caregivers.

    Herrera-Restrepo O, Afroz N, Cabrera ES, et al.

    Infectious diseases and therapy 2024; (13(12)):2563-2579 doi:10.1007/s40121-024-01060-8.

    PMID: 39467955
  37. 37

    Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10-12 years: phase III randomized trial complementary analysis of immune persistence 3-6 years after priming.

    Peterson J, Galarza K, Bchir S, et al.

    Pediatric research 2025; (97(6)):1800-1802 doi:10.1038/s41390-024-03760-w.

    PMID: 39672823
  38. 38

    [Community acquired bacterial meningitis in adults].

    Madlener M, Joost I

    Innere Medizin (Heidelberg, Germany) 2025; (66(2)):190-198 doi:10.1007/s00108-025-01851-2.

    PMID: 39888404
  39. 39

    Adjunctive dexamethasone and 30-day all-cause death after hospital admission in paediatric pneumococcal meningitis: a propensity score analysis.

    Giolito A, Levy C, Varon E, et al.

    The Lancet. Child & adolescent health 2025; (9(4)):255-261 doi:10.1016/S2352-4642(25)00029-X.

    PMID: 40113367
  40. 40

    Bacterial Meningitis.

    Bulaeva A, Derber C

    The Medical clinics of North America 2025; (109(3)):587-599 doi:10.1016/j.mcna.2024.12.012.

    PMID: 40185548
  41. 41

    Chronic meningococcal disease: Systematic literature review.

    Schulz LP, Gatti B, Milani GP, et al.

    Journal of infection and public health 2025; (18(11)):102900 doi:10.1016/j.jiph.2025.102900.

    PMID: 40768968
  42. 42

    Meningococcal Septic Shock Revealed: The Frightening Face of Serogroup B.

    Inceli BH, Penezoglu DN, Havan M, et al.

    Cureus 2025; (17(8)):e89950 doi:10.7759/cureus.89950.

    PMID: 40951008
  43. 43

    Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults.

    McMillan M, Buttery J, Angliss M, et al.

    The Pediatric infectious disease journal 2026; (45(1)):17-23 doi:10.1097/INF.0000000000004962.

    PMID: 40966756
  44. 44

    High risk and low incidence diseases: Meningococcal disease.

    Cejin MC, Koyfman A, Long B

    The American journal of emergency medicine 2026; (99()):114-122 doi:10.1016/j.ajem.2025.09.031.

    PMID: 41016083
  45. 45

    Atypical Presentation of Meningococcemia as Gastroenteritis in an Adult: A Case Report.

    Al-Anbagi U, Saad A, Ibrahim T, Nashwan AJ

    Cureus 2025; (17(9)):e92126 doi:10.7759/cureus.92126.

    PMID: 41084661
  46. 46

    Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025.

    Amin AB, Collins JP, Dong X, et al.

    MMWR. Morbidity and mortality weekly report 2026; (75(1)):7-14 doi:10.15585/mmwr.mm7501a2.

    PMID: 41505372